These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992) in children with acute leukemia and lymphoma. Tan CT; Hancock C; Steinherz PG; Steinherz LJ; Sorell M; Chan KW; Mondora A; Miller DR Cancer Res; 1982 Apr; 42(4):1579-81. PubMed ID: 6895864 [TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study. Miller LP; Miller DR; Tan CT Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604 [No Abstract] [Full Text] [Related]
11. Amsacrine alone or in combination with 5-azacytidine and etoposide in refractory or relapsed acute non lymphoblastic leukemia (ANLL). Carella AM; Santini G; Martinengo M; Nati S; Giordano D; Congiu A; Cerri R; Damasio E; Risso M; Rossi E Haematologica; 1985; 70(1):39-43. PubMed ID: 2408974 [No Abstract] [Full Text] [Related]
12. A phase I and II study of m-AMSA in acute leukaemia. Slevin ML; Shannon MS; Prentice HG; Goldman AJ; Lister TA Cancer Chemother Pharmacol; 1981; 6(2):137-40. PubMed ID: 6946878 [TBL] [Abstract][Full Text] [Related]
13. [Initial results of the use of L-asparaginase in acute leukemia in childhood]. Nigro N; Madon E; Baroncelli PG Minerva Pediatr; 1970 Mar; 22(11):536-9. PubMed ID: 5267828 [No Abstract] [Full Text] [Related]
14. m-AMSA in refractory lymphoma. A phase II trial of the Eastern Cooperative Oncology Group. Keller AM; Tsiatis AA; Neiman RS; Glick JH; Mann RB Am J Clin Oncol; 1985 Oct; 8(5):449-52. PubMed ID: 3840644 [TBL] [Abstract][Full Text] [Related]
15. [Eosinophilia in acute lymphoblastic leukemia and lymphosarcoma: indicator of immune responses? (author's transl)]. Kaufmann U; Lampert F Klin Padiatr; 1974 Nov; 186(6):492-9. PubMed ID: 4531501 [No Abstract] [Full Text] [Related]
16. AMSA--a promising new agent in refractory acute leukemia. Lawrence HJ; Ries CA; Reynolds RD; Lewis JP; Koretz MM; Torti FM Cancer Treat Rep; 1982 Jul; 66(7):1475-8. PubMed ID: 7046928 [TBL] [Abstract][Full Text] [Related]
17. Phase II study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study. Amrein PC; Coleman M; Richards F; Poulin RF; Bernhardt B; Ginsberg SJ; Green MR; Morrison A; Cortes E; Kiang D; Weinberg V; Wood WC Cancer Treat Rep; 1982 May; 66(5):1211-3. PubMed ID: 6896294 [No Abstract] [Full Text] [Related]
18. Leurosine sulfate (NSC-90636) in treatment of Hodgkin's disease, acute lymphoblastic leukemia, and lymphoblastic lymphosarcoma. Mathe G; Schneider M; Bond P; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR Cancer Chemother Rep; 1965 Dec; 49():47-9. PubMed ID: 5322839 [No Abstract] [Full Text] [Related]
19. Phase II trial of amsacrine in children with advanced metastatic neuroblastoma. De Bernardi B; Pastore G; Garaventa A; Calculli G; Carli M; Ceci A; di Montezemolo LC; Pianca C; Romano C; Russo A Cancer Treat Rep; 1984; 68(7-8):1051-2. PubMed ID: 6547640 [No Abstract] [Full Text] [Related]
20. [Betamethasone phosphate in hematology]. Bauters F Lille Med; 1971 Apr; 16():S 2:625-30. PubMed ID: 5293269 [No Abstract] [Full Text] [Related] [Next] [New Search]